MR [Mindray Medical International] SC 13D: JOINT FILING AGREEMENT This Joint Filing Agreement may

[JOINT FILING AGREEMENT This Joint Filing Agreement may be executed in any number of counterparts all of which together shall constitute one and the same instrument. [ Page 1 of 4 Li Xiting Magic Bell Limited Li Xiting Sole Director Quiet Well Limited Li Xiting Sole Director Page 2 of 4 Xu Hang New Dragon (No. 12) Investments Limited] []

MR [Mindray Medical International] SC 13G/A: (Original Filing)

[1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). EARNEST Partners, LLC ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Georgia ------------------------------------------------------------------------------- 5 SOLE VOTING POWER 2,538,342 NUMBER OF -----------------------------------------------------------------]

MR [Mindray Medical International] SC 13G/A: 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS.

[1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). EARNEST Partners, LLC ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Georgia ------------------------------------------------------------------------------- 5 SOLE VOTING POWER 2,538,342 NUMBER OF -----------------------------------------------------------------]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Receipt of "Going Private" Proposal at US$30.0 Per ADS or US$30.0 Per Ordinary Share The Board intends to form a special committee consisting of independent directors to consider this proposal. The Company cautions its shareholders and others considering trading in its securities that the Board just received the non-binding proposal and has not made any decisions with respect] []

MR [Mindray Medical International] 6-K: Mindray Announces Receipt of “Going Private” Proposal at

[Mindray Announces Receipt of "Going Private" Proposal at US$30.0 Per ADS or US$30.0 Per Ordinary Share The Board intends to form a special committee consisting of independent directors to consider this proposal. The Company cautions its shareholders and others considering trading in its securities that the Board just received the non-binding proposal and has not made any decisions with respect] []

MR [Mindray Medical International] SC 13G/A: 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS.

[1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). EARNEST Partners, LLC ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Georgia ------------------------------------------------------------------------------- 5 SOLE VOTING POWER 2,805,855 NUMBER OF -----------------------------------------------------------------]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces First Quarter 2015 Financial Results SHENZHEN, China, May 11, 2015 -- Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2015. Highlights for First Quarter 2015 - Net revenues increased 2.9% year-over-year to $272.5 million. o] []

MR [Mindray Medical International] 6-K: Mindray Announces First Quarter 2015 Financial Results SHENZHEN,

[Mindray Announces First Quarter 2015 Financial Results SHENZHEN, China, May 11, 2015 -- Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2015. Highlights for First Quarter 2015 - Net revenues increased 2.9% year-over-year to $272.5 million. o] []

Skip to toolbar